Clinical trial NCT04982003: Feasibility of Whole-body Drumming Classes for People With Parkinson's Disease
Official title: Feasibility and Effects of Whole-body Drumming Classes on Walking in People With Parkinson's Disease: a Pilot Study
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Parkinson Disease
Lead sponsor: A.T. Still University of Health Sciences
Sponsor class: OTHER
First posted: 2021-07-29
Enrollment: 38
Sex: ALL
Minimum age (years): 21
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: single group, pre- post-test design
Primary purpose: TREATMENT

Brief summary: People with Parkinson's disease (PD) experience difficulty with gait, postural instability, and lack of movement coordination and rhythmic timing. Non-motor functions affected by PD include time perception, feelings of apathy, depression, decreased self-efficacy, and decrease self-reported quality of life. There is currently a lack of information on how a therapeutic drumming class that uses whole-body large-amplitude movements to music would impact these motor and non-motor impairments in individuals with PD. The primary purpose of this study is to assess the feasibility of a 10-week whole-body drumming class to music specifically selected for its rhythmic structure, and effects on movement rhythm and time perception in individuals with PD. The secondary purpose is to assess the effects of the drumming class on apathy, depression, self-efficacy and health-related quality of life. Participants will be included if they have a diagnosis of PD and are able to move for an hour with rests, either standing or seated. Participants are tested before and after the class series and one month following.


Eligibility criteria: Inclusion Criteria:

* diagnosed with PD
* independent walking short community and household distances with or without assistive device
* able to participate in a 1-hour class once a week for ten weeks

Exclusion Criteria:

* change of Parkinson's medication or deep brain stimulation parameters within 2 weeks prior to or during the study
* inability to grasp 2-inch diameter "drum sticks"
* any conditions with contraindications to lift upper extremities overhead
* any medical restrictions to exercise

Primary outcomes:
measure: Step Cadence Variability
timeFrame: within 7 days before the intervention
measure: Step Cadence Variability
timeFrame: within 7 days after intervention
measure: Step Cadence Variability
timeFrame: 1-month following intervention
measure: Stride Length Variability
timeFrame: within 7 days before the intervention
measure: Stride Length Variability
timeFrame: within 7 days after intervention
measure: Stride Length Variability
timeFrame: 1-month following intervention
measure: Change in repeated finger-tapping
timeFrame: within 7 days before the intervention and within 7 days after intervention
measure: Change in repeated finger-tapping
timeFrame: within 7 days before the intervention and 1-month following end of intervention
Secondary outcomes:
measure: Change in Nine-hole peg test (NHP) duration (s)
timeFrame: within 7 days before the intervention and within 7 days after intervention
measure: Change in Nine-hole peg test (NHP) duration (s)
timeFrame: within 7 days before the intervention, and 1-month following intervention
measure: Change in Physical Performance Test (PPT) score
timeFrame: within 7 days before the intervention and within 7 days after intervention
measure: Change in Physical Performance Test (PPT) score
timeFrame: within 7 days before the intervention, and 1-month following intervention
measure: Change in Parkinson Disease Questionnaire (PDQ-39)
timeFrame: within 7 days before the intervention and within 7 days after intervention
measure: Change in Parkinson Disease Questionnaire (PDQ-39)
timeFrame: within 7 days before the intervention, and 1-month following intervention
measure: Geriatric Depression Scale (GDS)
timeFrame: within 7 days before the intervention and within 7 days after intervention
measure: Geriatric Depression Scale (GDS)
timeFrame: within 7 days before the intervention, and 1-month following intervention
measure: General Self-Efficacy scale (GSE)
timeFrame: within 7 days before the intervention and within 7 days after intervention
measure: General Self-Efficacy scale (GSE)
timeFrame: within 7 days before the intervention, and 1-month following intervention
measure: Lille Apathy Rating Scale (LARS)
timeFrame: within 7 days before the intervention and within 7 days after intervention
measure: Lille Apathy Rating Scale (LARS)
timeFrame: within 7 days before the intervention, and 1-month following intervention
Other outcomes:
Locations:
city: Mesa
country: United States
facility: A.T. Still University Arizona School of Health Sciences
state: Arizona
Study officials:
affiliation: A.T. Still University
name: Tara L McIsaac, PhD, PT
role: PRINCIPAL_INVESTIGATOR
References: